Related Experiment Video
Updated: Jul 16, 2026
13:21
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
Ethyl pyruvate: a novel anti-inflammatory agent
1Departments of Critical Care Medicine, Pharmacology and Surgery, University of Pittsburgh Medical School, Pittsburgh, PA 15261, USA. finkmp@ccm.upmc.edu
Journal of Internal Medicine
|March 30, 2007
Summary
Ethyl pyruvate (EP) shows promise for treating critical illnesses by improving survival and reducing organ damage. This pyruvate derivative has distinct anti-inflammatory effects and is safe in humans, warranting further clinical investigation.
Area of Science:
- Biochemistry
- Pharmacology
- Critical Care Medicine
Background:
- Ethyl pyruvate (EP) is a derivative of pyruvic acid, an endogenous metabolite.
- EP has demonstrated efficacy in preclinical models of critical illnesses like sepsis, ARDS, pancreatitis, and stroke.
- Initially viewed as a pyruvate delivery method, EP now shows distinct pharmacological properties beyond pyruvate anion effects.
Purpose of the Study:
- To explore the therapeutic potential of ethyl pyruvate (EP) in critical illnesses.
- To investigate the pharmacological effects of EP, distinguishing them from pyruvate anion.
- To assess the safety and potential clinical utility of EP in human diseases.
Main Methods:
- Preclinical studies in various critical illness models (sepsis, ARDS, pancreatitis, stroke).
- Evaluation of survival rates and organ dysfunction.
- Human volunteer safety trials at clinically relevant doses.
Main Results:
- EP improved survival and ameliorated organ dysfunction in multiple preclinical critical illness models.
- EP exhibits pharmacological effects, including inflammation suppression, distinct from pyruvate anion.
- EP has been confirmed safe in human volunteers at clinically relevant doses.
Conclusions:
- Ethyl pyruvate demonstrates significant therapeutic potential in preclinical models of critical illness.
- EP possesses unique anti-inflammatory properties separate from pyruvate.
- EP is safe for human use, supporting further clinical trials for disease treatment.
